What is so bad about reverse epidemiology anyway

作者: Kamyar Kalantar-Zadeh

DOI: 10.1111/J.1525-139X.2007.00360.X

关键词:

摘要: The term "reverse epidemiology" is used to indicate that such surrogates of cardiovascular risk and metabolic syndrome as obesity, hypercholesterolemia hypertension are paradoxically associated with greater survival in individuals chronic disease states wasting, including dialysis patients, whom the short-term issue at hand. It being debated whether crossing curves obesity-mortality association patients vs. general population reflect residual confounding needs be controlled away statistically, or they have biological plausibility sharp contradistinction currently dominating Framingham paradigm. In rush define statistical artifact dismiss a misnomer, we may miss opportunity gain information housed those lines bigger picture, i.e., how improve longevity patients. Even though some paradoxes appear fulfill Hill's criteria causation, there still two major drawbacks: (1) convincing pathophysiologic pathways link patient fat accumulation, higher serum lipoprotein levels slightly than normal blood pressure values yet verified animal other scientifically sound models; (2) randomized trials need show nutritional interventions resulting weight can lead Studying paradigm shift by establishing targets beyond guidelines for populations states.

参考文章(107)
J. Plutzky, PPARs as Therapeutic Targets: Reverse Cardiology? Science. ,vol. 302, pp. 406- 407 ,(2003) , 10.1126/SCIENCE.1091172
Kamyar Kalantar-Zadeh, Joel D. Kopple, Obesity paradox in patients on maintenance dialysis. Contributions To Nephrology. ,vol. 151, pp. 57- 69 ,(2006) , 10.1159/000095319
LG Futterman, L Lemberg, The Framingham Heart Study: a pivotal legacy of the last millennium. American Journal of Critical Care. ,vol. 9, pp. 147- 151 ,(2000) , 10.4037/AJCC2000.9.2.147
WORKGROUP KD, None, K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. American Journal of Kidney Diseases. ,vol. 45, ,(2005)
Kamyar Kalantar-Zadeh, Kevin C Abbott, Abdulla K Salahudeen, Ryan D Kilpatrick, Tamara B Horwich, Survival advantages of obesity in dialysis patients The American Journal of Clinical Nutrition. ,vol. 81, pp. 543- 554 ,(2005) , 10.1093/AJCN/81.3.543
Paul E. Barre, John D. Harnett, Gloria M. Kent, David C. Murray, Robert N. Foley, Patrick S. Parfrey, HYPOALBUMINEMIA, CARDIAC MORBIDITY, AND MORTALITY IN END-STAGE RENAL DISEASE Journal of The American Society of Nephrology. ,vol. 7, pp. 728- 736 ,(1996) , 10.1681/ASN.V75728
Susie Q. Lew, Felicia Cohn, Lewis M. Cohen, Paul L. Kimmel, Ethical issues in aging and renal disease. Advances in Renal Replacement Therapy. ,vol. 7, pp. 63- 69 ,(2000) , 10.1016/S1073-4449(00)70007-0
Kamyar Kalantar-Zadeh, Kevin C. Abbott, Florian Kronenberg, Stefan D. Anker, Tamara B. Horwich, Gregg C. Fonarow, Epidemiology of dialysis patients and heart failure patients. Seminars in Nephrology. ,vol. 26, pp. 118- 133 ,(2006) , 10.1016/J.SEMNEPHROL.2005.09.005
Kamyar Kalantar-Zadeh, Amy Braglia, Joanne Chow, Osun Kwon, Noriko Kuwae, Sara Colman, David B. Cockram, Joel D. Kopple, An Anti-Inflammatory and Antioxidant Nutritional Supplement for Hypoalbuminemic Hemodialysis Patients: A Pilot/Feasibility Study Journal of Renal Nutrition. ,vol. 15, pp. 318- 331 ,(2005) , 10.1016/J.JRN.2005.04.004
F MACDONALD, QUETELET INDEX AS INDICATOR OF OBESITY The Lancet. ,vol. 327, pp. 1043- ,(1986) , 10.1016/S0140-6736(86)91321-8